2006
11.12.2006
Antitope Present at "Antibody Therapeutics" at San Diego, USA
Antitope Present at "Antibody Therapeutics" at San Diego, USA, Dec 12th 2006 Dr Frank Carr, Director of Biologics Research will be presenting a paper entitled "Composite Human Antibodies - Combined Humanization, Deimmunization and Fully Human Antibodies"
Antitope Present at "Antibody Therapeutics" at San Diego, USA
Antitope Present at "Antibody Therapeutics" at San Diego, USA, Dec 12th 2006 Dr Frank Carr, Director of Biologics Research will be presenting a paper entitled "Composite Human Antibodies - Combined Humanization, Deimmunization and Fully Human Antibodies"
09.07.2006
Antitope and VasGene Therapeutics Announce the Successful Generation of Two Therapeutic Antibodies
Antitope Limited, UK. and VasGene Therapeutics, Inc. Announce the Successful Generation of Two Therapeutic Antibodies July 2006 Antitope Ltd., a leader in the generation of therapeutic human antibodies, and VasGene Therapeutics, Inc., a leader in the development of therapeutics based on new...
Antitope and VasGene Therapeutics Announce the Successful Generation of Two Therapeutic Antibodies
Antitope Limited, UK. and VasGene Therapeutics, Inc. Announce the Successful Generation of Two Therapeutic Antibodies July 2006 Antitope Ltd., a leader in the generation of therapeutic human antibodies, and VasGene Therapeutics, Inc., a leader in the development of therapeutics based on new...
14.05.2006
Antitope Announces Antibody Research Agreement with Elusys Therapeutics, Inc
Antitope Announces Antibody Research Agreement with Elusys Therapeutics, Inc 15th May 2006 Antitope Ltd., a leader in the development of Composite Human Antibody™ technology for the generation of therapeutic antibodies of entirely human origin announced a research agreement with Elusys...
Antitope Announces Antibody Research Agreement with Elusys Therapeutics, Inc
Antitope Announces Antibody Research Agreement with Elusys Therapeutics, Inc 15th May 2006 Antitope Ltd., a leader in the development of Composite Human Antibody™ technology for the generation of therapeutic antibodies of entirely human origin announced a research agreement with Elusys...